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Objective: We sought to compare early and midterm clinical outcomes in patients
receiving a right internal thoracic artery or a radial artery as the second arterial
conduit for myocardial revascularization.
Methods: Data prospectively collected for all patients who underwent coronary
artery bypass surgery between April 1996 and May 2001 and who received both a
left internal thoracic artery graft and either a right internal thoracic artery (n  336)
or a radial artery graft (n  325) were analyzed. Patients in the radial artery group
were older, with a greater body mass index, poorer ejection fraction, greater
prevalence of diabetes, and higher New York Heart Association class than those in
the right internal thoracic artery group.
Results: Odds ratios for perioperative myocardial infarction, atrial fibrillation,
postoperative transfusion, and intensive care unit stay all showed a statistically
significant benefit in the radial artery group compared with results in the right
internal thoracic artery group (P .05). Survival estimates at 18 months for patients
who received right internal thoracic artery and radial artery grafts were 98.4% and
99.7%, respectively (hazard ratio, 0.25; 95% confidence interval, 0.06-1.10; P 
.07). Estimates for survival free from any cardiac-related event or death in the right
internal thoracic artery and radial artery groups were 92.3% and 97.8%, respectively
(hazard ratio, 0.37; 95% confidence interval, 0.16-0.84; P  .02). A multivariate
Cox regression model showed a stronger protective effect of a radial artery graft
(hazard ratio, 0.25; 95% confidence interval, 0.12-0.51; P  .0001).
Conclusion: Early and midterm outcomes of myocardial revascularization with 2
arterial grafts are better if the radial artery is used for the second graft rather than
the right internal thoracic artery, assuming that the left internal thoracic artery is
used for the first arterial graft.
The benefits of a left internal thoracic artery (LITA) graft to the leftanterior descending coronary artery (LAD) have been well docu-mented, particularly with respect to long-term patency survival,cardiac event–free survival, and conduit patency rates, when com-pared with results with saphenous vein grafts.1-4 This has lead to thewidespread use of arterial coronary revascularization techniques.
After the first disappointing experience more than 2 decades ago,5 Acar and
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colleagues6 stimulated renewed interest in the use of the
radial artery (RA) in coronary artery bypass grafting
(CABG). Since then, many groups have reported encourag-
ing short-term and midterm clinical and angiographic re-
sults with this conduit.7-10 On the other hand, the use of the
right internal thoracic artery (RITA) as a second arterial
graft has been shown to decrease the risk of death, reopera-
tion, and percutaneous transluminal coronary angioplasty
when compared with a single-LITA strategy.11-13 Bilateral
thoracic artery use is, however, still limited because of the
increased operative time, the potentially increased morbid-
ity rate, and the technical complexity of the operation.
Moreover, some investigators have reported contradictory
results in relation to additional survival benefits.14,15 At our
institution, we started using the RA for coronary revascu-
larization in 1996 as an additional alternative arterial con-
duit of the RITA for multiple arterial revascularization. The
aim of this study was therefore to compare early and mid-
term (5 years) outcomes in patients receiving an RITA
versus those receiving an RA as the second arterial conduit.
Methods
Patient Selection and Data Collection
A standard set of perioperative data are collected prospectively for
all patients undergoing CABG at our institution. The data set
includes 5 different sections to be filled in consecutively by the
anesthetist, surgeon, intensive therapy unit personnel, high depen-
dency unit personnel, and ward nurses. Data are entered into a
database (Patient Analysis and Tracking Systems; Dendrite Clin-
ical Systems, London, United Kingdom). This article analyses data
for all patients who underwent CABG between April 1, 1996, and
May 12, 2001, and who received both an LITA graft and either an
RITA or an RA graft. Patients who did not receive an LITA graft
or who received additional arterial grafts (eg, RITA and RA grafts)
were excluded.
Anesthetic and Surgical Technique
Anesthetic technique, heparin management, and conductance of
cardiopulmonary bypass were standardized and have previously
been reported.16 Myocardial protection was achieved by using
intermittent anterograde hyperkalemic warm blood cardioplegia.17
During the period of the study, the unit has adopted the technique
of off-pump surgery and now uses this method with increasing
frequency; patients having their operation by means of either
technique were eligible. The method of exposure and stabilization
used to perform the anastomosis in patients who underwent off-
pump surgery has been described previously.18
The ITA harvesting was carried out by using a diathermy
technique (the entire vascular pedicle is taken down en bloc with
about 1-2 cm of surrounding tissue on either side). Lateral inter-
costal branches were divided between ligature clips rather than
cauterized. The RA was dissected through a skin incision starting
2 cm distal to the elbow and ending 3 cm proximal to the wrist.19
The RA graft was used only in patients with a palpable ulnar
pulse and a negative Allen test result. The LITA was used as an in
situ graft, generally to revascularize the LAD territory, whereas the
RITA or RA was preferentially directed to the circumflex and right
coronary artery territories. The choice of using an RA or RITA as
the second arterial conduit was entirely at the discretion of the
operating surgeon and often based on the patient’s preoperative
characteristics and coronary anatomy. The RA was generally pre-
ferred to the RITA for patients with diabetes, obesity, poor ejection
fraction, and respiratory impairment.
Postoperative Management
At the end of the operation, patients were transferred to the
intensive therapy unit (ITU) and managed according to the unit
protocol.16
In-hospital mortality was defined as any death that occurred
within 30 days of the operation. Clinical diagnostic criteria for
perioperative myocardial infarction (MI) were new Q waves of
greater than 0.04 ms or a reduction in R waves of greater than 25%
in at least 2 leads. ST-segment changes, inotropic support, pacing
requirements, and arrhythmias were recorded and defined as pre-
viously reported.16 Pulmonary complications included chest infec-
tion, ventilation failure, reintubation, and tracheostomy. Postoper-
ative blood loss was defined as total chest tube drainage.
Neurologic complications included permanent and transient stroke.
Renal complications included acute renal failure, as defined by the
requirement for hemodialysis, or a postoperative creatinine level of
greater than 200 mol/L. Finally, infective complications included
septicemia and sternal and leg wound infections, as defined by
positive culture and administration of antibiotic therapy.
We aim to discharge patients undergoing CABG on the fifth
postoperative day. The suitability of patients to be discharged
home is made by an independent physician according to our unit
protocol.16
Patient Follow-up
Follow-up was performed during outpatient visits at 6 weeks, 3
months, and 1 year after the operation and then during telephone
interview with the patient.
Patients were assessed for survival and cardiac events, which
included the need for a further coronary revascularization proce-
dure (reoperation or percutaneous transluminal coronary angio-
plasty) or coronary angiography, MI, congestive heart failure,
arrhythmia, or recurrent angina. Clinical diagnostic criteria for all
cardiac events other than recurrence of angina have been previ-
ously reported.16 Recurrence of angina was evaluated clinically
and supported by means of exercise electrocardiographic testing.
Hospital admissions were examined by obtaining the clinical notes
or by means of general practitioner telephone interview to confirm
or ascertain diagnosis and treatment.
Sample Size
The analysis included data for all patients who were operated on
during the stated period and who received 2 arterial grafts. There
were approximately the same number of patients with an RA as
with an RITA graft. For dichotomous outcomes, this allocation
ratio and the total available sample size of 661 patients meant that
the study had 80% power to detect an absolute decrease in risk of
about 9% (ie, 25% vs 16%) or an absolute increase in risk of about
10% (ie, 25% vs 35%) in the RA group if the probability of the
outcome was 25% in the RITA group. For rarer events (eg, if the
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probability of the outcome was 10% in the RITA group), the study
had 80% power to detect an absolute decrease in risk of about 6%
(ie, 10% vs 4%) or an absolute increase in risk of about 10% (ie,
10% vs 18%). Changes of these magnitudes in the probability of an
outcome were considered to be clinically important.
Statistical Analysis
First, several known prognostic variables were compared between
the RITA and RA groups. All prognostic variables associated with
type of operation (Table 1) were considered to be potential con-
founding factors. Short-term outcomes for the RITA and RA
groups were compared both with and without adjusting for possi-
ble confounding by using multiple linear or logistic regression
(STATA version 7.0), depending on whether the outcome was a
dichotomous or continuous variable. Midterm outcomes were
compared between groups by using survival analyses (Cox regres-
sion). All analyses calculated robust confidence intervals (CIs),
taking account of clustering of patients within surgeon categories.
Some outcomes were dichotomized, total length of stay and blood
loss were transformed into natural logarithms to normalize the
distributions, and postoperative hemoglobin was analyzed in nat-
ural units. The number of prognostic variables and outcomes of
interest resulted in a large number of statistical comparisons. No
correction was made for multiple comparisons, but CIs and exact
P values are presented throughout. Our interpretation of the find-
ings takes into account the consistency of the findings and their
magnitude, as well as their statistical significance.
Results
A total of 4222 patients underwent CABG at our institution
between April 1, 1996, and May 12, 2001 (hospital mortal-
ity, 1.2%). Of these, 661 patients received 2 arterial grafts,
one with the LITA and the other either with the RITA (336
[50.8%]) or the RA (325 [49.2%]). The proportion of op-
erations using the RA increased steadily during the study
period (Figure 1).
The RITA graft was used as a pedicle graft in 94% of
cases and for the rest as a free graft. The RA was used as a
free graft in 78% of cases, and in the remaining cases it was
connected end to side to the LITA with a technique de-
scribed by Tector and colleagues.20
The distributions of a wide range of prognostic charac-
teristics in the RITA and RA groups are shown in Table 1.
Several of the prognostic characteristics were distributed
unevenly (P  .05), with the RA group containing, on
average, patients at higher risk (ie, older patients, more
female patients, higher body mass indexes, more patients
with a worse ejection fraction, more diabetic patients, and,
on average, higher New York Heart Association class and
Parsonnet score). However, the proportion of patients in the
RITA group who received grafts to both the LAD and
circumflex arteries was lower than that in the RA group. The
proportion of patients in the RITA group who underwent
on-pump surgery was higher, and, on average, patients in
the RITA group had more urgent need for surgical inter-
vention and required more distal anastomoses.
Early Outcomes
The distributions of early mortality and morbidity are de-
scribed in Table 2, and the unadjusted and adjusted effect
sizes comparing the RA and RITA groups are shown in
Table 3.
The unadjusted odds ratios for perioperative MI, atrial
fibrillation, postoperative transfusion, ITU stay of greater
than 1 day, and ITU or high dependency unit stay of greater
than 2 days all showed a statistically significant benefit from
having an RA rather than an RITA graft (P  .05).
Adjusting for prognostic variables that were distributed
unevenly between groups, including the site of anastomosis
of the 2 arterial grafts, did not substantially alter these
findings. The odds ratio estimates shifted further from unity,
indicating an even larger benefit from an RA compared with
an RITA graft, as would be expected given that the RA
group included patients who were, on average, at higher risk
of adverse outcomes.
Midterm Outcomes
Midterm outcome data for death and cardiac-related events
were available for 655 (99%) of 661 members of the study
population. The distributions of all deaths and cardiac-
related events during follow-up are shown in Table 4. Al-
most all types of event occurred more often in the RITA
group, but this simple comparison does not take account of
differences in the duration of follow-up between groups,
which arose because operations with the RA tended to have
been carried out more recently. The median duration of
follow-up was 655 days (1.79 years) for patients who re-
ceived an RITA graft and 564 days (1.54 years) for patients
who received an RA graft.
Survival estimates (ie, for all causes of death) at 18
months, without adjusting for covariates, were 98.4% (95%
CI, 96.1%-99.3%) in the RITA group and 99.7% (95% CI,
97.8%-100.0%) in the RA group (hazard ratio for RA graft,
0.25; 95% CI, 0.06-1.10; P  .07; Figure 2, A). Because
there were so few deaths, it was not possible to fit a
multivariate Cox regression model to take account of all
prognostic variables that differed between groups. How-
ever, a Cox model taking account of the main imbalances
between groups with respect to prognostic factors (Parson-
net score, sex, diabetes, and the site of the arterial grafts)
showed a stronger protective effect of an RA graft against
all causes of death (hazard ratio, 0.18; 95% CI, 0.05-0.66;
P  .01).
Estimates for survival free from any cardiac-related event or
death at 18 months, without adjusting for covariates, were
92.3% (95% CI, 88.6%-94.8%) in the RITA group and 97.8%
(95% CI, 94.7%-99.1%) in the RA group (hazard ratio for RA
graft, 0.37; 95% CI, 0.16-0.84; P  .02; Figure 2, B). A
multivariate Cox regression model taking account of the main
imbalances between groups with respect to prognostic factors
(age, sex, diabetes, ejection fraction, Parsonnet score, pre-
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operative New York Heart Association classification, and site
of the arterial grafts) showed a stronger protective effect of an
RA graft against all causes of death (hazard ratio, 0.25; 95%
CI, 0.12-0.51; P  .0001).
TABLE 1. Distribution of prognostic variables
Prognostic variable (nRITA/nRA) when there were
missing data
RITA (n  336) RA (n  325)
P valuen % n %
Date of the operation  .0001
April 1, 1996 to March 31, 1999 191 56.9 123 37.9
April 1, 1999 to March 31, 2000 102 30.4 97 29.9
April 1, 2000 to May 12, 2001 43 12.8 105 32.3
Age at the operation (y)* 55.5 7.8 57.7 8.1 .0003
Body mass index (n  334/323)* 27.5 3.2 28.2 3.9 .02
Female sex 29 8.6 51 15.7 .005
Risk factors
Fair or poor ejection fraction (n  334/324) 46 13.8 85 26.2  .0001
Previous myocardial infarction (n  336/324) 127 37.8 137 42.3 .24
Previous stroke (n  335/324) 9 2.7 18 5.6 .06
Serum creatinine  120 mol/dL (n  332/322) 53 16.0 53 16.5 .86
Respiratory impairment (n  335/325) 21 6.3 28 8.6 .25
Redo CABG 9 2.7 17 5.2 .09
Diabetes (n  336/324) 21 6.3 59 18.2  .0001
Hypercholesterolemia 276 82.1 263 80.9 .69
Hypertension 167 49.1 267 51.4 .67
Canadian classification score .22
1 27 8.0 33 10.2
2 125 37.2 97 29.9
3 105 31.3 115 35.4
4 79 23.5 80 24.6
NYHA score .02
1 98 29.2 87 26.8
2 167 49.7 136 41.9
3 64 19.1 87 26.8
4 7 2.1 15 4.6
Extent of coronary heart disease (n  336/324) .85
Two affected vessels 122 36.3 120 37.0
Three affected vessels 214 63.7 204 63.0
Smoking history .88
Never smoked 75 22.3 74 22.8
Past smoker 198 58.9 195 60.0
Current smoker 63 18.8 56 17.2
Preoperative arrhythmia 6 1.8 6 1.9 .95
Parsonnet score .001
0-5 292 86.9 243 74.8
6-10 30 8.9 62 19.1
11-15 11 3.3 14 4.3
15 3 0.9 6 1.9
Urgent operation 168 50.0 136 41.9 .04
No. of distal anastomoses (n  336/324) .02
2 130 38.7 145 44.8
3 146 43.5 145 44.8
4 60 17.9 34 10.5
Site of RITA/RA graft (n  336/324)  .0001
Right coronary/PD artery 178 53.0 124 38.2
Circumflex artery 105 31.3 188 57.9
LAD 53 15.8 13 4.0
Arterial grafts (LITA and RITA/RA) to both LADs,
and circumflex arteries
158 47 201 61.8 .001
On-pump surgery 258 76.8 197 60.6  .0001
PD, Posterior descending; NYHA, New York Heart Association.
*Mean and SD shown for continuously distributed variables.
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Discussion
The increasing interest in the use of the RA as a coronary
bypass graft has been based on encouraging early and
midterm clinical and angiographic results6-10 and the well-
documented long-term failure of saphenous vein con-
duits.1-4 A review of the literature21 shows that the early
average patency rate and perfect patency rate (within 6
months) of the RA is 98% and 90.8%, respectively, and the
rate of perioperative morbidity and mortality is well within
the usual range for primary coronary operations. Five-year
RA perfect patency rates have been recently reported by
Acar and colleagues7 and by Possati and associates8 to be
85% and 87%, respectively. On the other hand, the excellent
results obtained with the LITA have led to the use of both
thoracic arteries for myocardial revascularization,22 and re-
cently, 2 large-scale studies and a systematic review have
shown that long-term survival with both thoracic arteries is
better than that with a single thoracic artery.12,13,23 Other
studies have reported contradictory results about additional
survival benefits with bilateral thoracic arteries for myocar-
dial revascularization.14,15 These conflicting results, as well
as a longer and more technically demanding operation, are
the probable reasons for the relative lack of popularity of
bilateral thoracic artery harvesting.24
The present observational study showed that the use of
the RA as a second arterial conduit of choice is associated
with several early and midterm clinical advantages com-
pared with the use of the RITA. The RA could be harvested
in almost every patient because clinical contraindications
(positive Allen test result, need for hemodialysis, history of
previous vascular trauma to the upper limbs, and presence
of Raynaud or Dupuytren disease) were quite rare. The
higher prevalence of diabetes, elderly age, chronic obstruc-
tive pulmonary disease, and worse ejection fraction in the
RA group reflects our concerns with respect to sternal
infection after bilateral ITA grafting, which was therefore
reserved for a selected group of younger, nonobese, non–
insulin-dependent diabetic patients.
The attractions of the RA compared with the RITA
during the operation are obvious. It is a versatile conduit
that can be harvested easily and safely, it has handling
characteristics superior to those of the RITA, and it reaches
comfortably any coronary artery target, features making it
more versatile during the operation and rendering the cor-
onary anastomosis easier and faster to perform.
Mortality was similar for the RITA and RA groups,
despite a higher prevalence of risk factors in the RA group.
Patients receiving an RA had a significantly lower incidence
of perioperative MI and atrial fibrillation compared with
patients receiving an RITA. Furthermore, postoperative
bleeding and red cell transfusion requirements were signif-
icantly less in the RA group, and this was associated with a
shorter ITU stay. However, there was no difference regard-
ing the incidence of chest reopening for bleeding between
the 2 groups, as reported by Lemma and coworkers25 and by
Borger and colleagues.26 In both these studies, there was a
lower incidence of sternal wound complications in the RA
group and a reduced hospital stay. Our results did not show
a statistically significant difference in the incidence of ster-
nal wound infection between the 2 groups, which might
explain the fact that we did not observe a difference in
hospital stay.
Midterm survival free from any cardiac-related events or
death showed significant advantages when the RA graft was
used for myocardial revascularization compared with when
the RITA graft was used. Other reports7,8 have demon-
strated low mortality rates, excellent survival curves, and
encouraging 5-year patency rates with the use of the RA. To
the best of our knowledge, only one small study26 has
compared the midterm results in patients receiving the
RITA or RA as the second arterial graft, and their results
showed a nonsignificantly higher survival free from cardiac
events in the RA group.
Limitations of the Study
Could our results be explained by bias, confounding, or
chance? Chance is unlikely, given the consistent direction of
effect size estimates and the strength of the findings for
several outcomes.
It might be argued that without blinding of the patients
and their caretakers, some of the short-term outcomes could
be biased by knowledge of the type of arterial graft. How-
ever, we believe that bias from a lack of blinding is unlikely
to be an explanation for the results. First, none of the health
care staff were aware when collecting-recording the data
Figure 1. Percentage of RA and RITA grafts by year: filled squares,
RA; shaded squares, RITA. Data for each year are from April 1 to
March 31 of the following year, except for the year 2000, which
includes data up to May 12, 2001.
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that the comparison between RA and RITA grafts was going
to be made. Second, as described above, strict local guide-
lines are used to make decisions about transfusion because
it is unethical to expose a patient to the risks of transfusion
unnecessarily. These guidelines were applied carefully
throughout the period of the study and would have mini-
mized the opportunity for bias. Third, there are similar local
guidelines for use of ITU and high dependency unit beds;
these resources are limited, and there are strong pressures to
implement the guidelines to maintain the workload of the
unit.
Bias could also have arisen from missing data if there
was a tendency for data to be missing selectively for the
highest risk patients who received an RA graft. It can be
seen from Tables 2 and 3 that there were few missing data
(5%) for all prognostic variables and for all outcomes,
with the exception of blood loss, transfusion requirement,
and postoperative hemoglobin. Data for these variables
were not collected from April 1996 to April 1997, which
accounts for the majority of missing data. Bias from missing
data is therefore unlikely.
Without random allocation, it is not possible to exclude
the possibility that the findings arise from confounding.
However, we believe that confounding is unlikely to explain
the benefits observed in the RA group for several reasons. It
is certainly the case that allocation of patients to receive an
RITA or RA graft did not happen arbitrarily. However,
surgeons have generally preferred to use the RITA as a
second arterial graft,12 with the RA used as second best
when it is technically difficult or dangerous for the patient
(with respect to postoperative morbidity) to use the RITA.
The increase in the use of RA grafts over time is the result
of the encouraging reports in the literature and also the
increased number of high-risk patients (with poor-moderate
ejection fractions, diabetes, higher Parsonnet scores, and
more urgent operations) undergoing CABG during the study
period. That this was indeed the basis for allocating patients
to the RITA or RA groups is supported by the observed
TABLE 2. Distributions of outcomes
Outcome (nRITA/nRA) when there were missing data
RITA (n  336) RA (n  325)
n % n %
Deaths in the hospital 3 0.9 1 0.3
Perioperative myocardial infarction (n  336/324) 7 2.1 1 0.3
Inotropes on recovery (n  335/321) 78 23.3 71 22.1
Postoperative atrial fibrillation (n  336/324) 32 9.6 13 4.0
Neurologic complication (n  336/324) 2 0.6 2 0.6
Respiratory complication (n  336/324) 23 6.9 19 5.9
Ventilated 12 h (n  336/324) 83 24.8 72 22.3
Renal complication (n  336/324) 8 2.4 5 1.5
Infective complication (n  336/324) 5 1.3 7 1.9
Blood loss  1000 mL (n  281/270) 138 49.1 125 46.3
In (blood loss) (n  281/270)* 6.89 0.55 6.84 0.44
Postoperative hemoglobin† (g/L) (n  291/288)* 10.3 1.3 10.3 1.2
Postoperative transfusion (n  297/295)* 139 46.8 44 14.9
ITU stay (d)
0 29 8.6 26 8.0
1 239 71.1 249 76.6
2 37 11.0 26 8.0
3 17 5.1 17 5.2
4 14 4.2 7 2.2
Combined ITU and high dependency unit stay (d) (n  334/320)
1 31 9.3 32 10.0
2 156 46.7 169 52.8
3 71 21.3 68 21.3
4 46 13.8 28 8.8
5 30 9.0 23 7.2
Total length of stay (d) (n  330/321)†
0-7 253 76.7 248 77.3
8-10 47 14.2 47 14.6
11-15 20 6.1 14 4.4
16 10 3.0 12 3.7
In (length of stay) (n  330/321)*‡ 1.89 0.33 1.88 0.35
*Mean and SD shown for continuously distributed variables.
†At 48 hours postoperatively.
‡Excluding length of stay for 4 patients who died in the hospital.
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distribution of prognostic factors between groups, with the
direction of any imbalance between groups almost always
being such that the RA group was at higher risk. Given that
patients in the RA group were, on average, at higher risk,
confounding could only cause the protective effect of an RA
graft to be underestimated. This is demonstrated by the
tendency for effect size estimates to become more extreme
after adjustment for prognostic variables recorded in the
database.
The site of grafting was an exception to this rule, with
more patients in the RITA than RA groups having the
second arterial graft placed on the right coronary system
rather than on the circumflex artery. However, this con-
straint on grafting of the RITA did not explain the poorer
outcomes in the RITA group because the protective effect of
an RA graft remained after adjusting for the fact that pa-
tients in the RITA graft were more likely to have the second
graft placed on the right coronary artery.
Finally, it might be argued that a median duration of
follow-up of 18 to 21 months is too short to be clinically
TABLE 3. Effect of RA versus RITA graft on mortality and morbidity outcomes; Unadjusted and adjusted effect sizes
Outcome
Unadjusted effect size Adjusted effect size*
OR/mean difference 95% CI P value OR/mean difference 95% CI P value
In-hospital deaths 0.34 0.03 to 3.30 .35 0.06 0.00 to 1.08 .06
Perioperative myocardial
infarct
0.15 0.02 to 1.03 .05 0.14 0.02 to 0.93 .04
Inotropes on recovery 0.94 0.63 to 1.38 .74 0.92 0.58 to 1.45 .72
Postoperative atrial fibrillation 0.40 0.25 to 0.62 .001 0.34 0.21 to 0.54 .001
Neurologic complication 1.04 0.16 to 6.69 .97 1.43 0.09 to 23.2 .80
Respiratory complication 0.85 0.40 to 1.79 .67 0.89 0.41 to 1.92 .76
Ventilated 12 h 0.87 0.58 to 1.31 .50 0.81 0.50 to 1.31 .39
Renal complication 0.64 0.34 to 1.23 .18 0.71 0.35 to 1.43 .34
Infective complication 1.83 0.66 to 5.13 .25 1.25 0.42 to 3.69 .69
Blood loss 1000 mL 0.89 0.64 to 1.25 .51 0.84 0.59 to 1.20 .33
In (blood loss)† 0.05† 0.14 to 0.03 .20 0.05† 0.12 to 0.03 .21
Postoperative hemoglobin‡
(g/dL)
0.07† 0.24 to 0.11 .42 0.05† 0.22 to 0.13 .58
Postoperative transfusion 0.20 0.14 to 0.29 .001 0.03 0.01 to 0.12 .001
1 ITU d 0.72 0.52 to 0.99 .04 0.62 0.38 to 1.00 .05
2 ITU or high dependency
unit d
0.75 0.59 to 0.95 .02 0.69 0.49 to 0.99 .04
Length of stay 7 d§ 0.97 0.60 to 1.56 .89 0.91 0.57 to 1.47 .71
In (length of stay)†§ 0.01† 0.09 to 0.07 .81 0.02† 0.11 to 0.07 .63
*Mean difference and 95% CI for the difference shown for continuously distributed variables.
†At 48 hours postoperatively.
‡Excluding length of stay for 4 patients who died in the hospital.
§Adjusted for age at operation, date of operation, sex, body mass index, preoperative Canadian cardiac score, preoperative NYHA classification, ejection
fraction, previous Cardiovascular accident/transient ischemic attack, extent of coronary disease, diabetes, Parsonnet score, operative priority, number of
distal anastomoses, on/off-pump surgery, and target artery for the RITA/RA graft.
TABLE 4. Distribution of cardiac-related events by RA versus RITA arterial graft*
Outcome† (nRITA/nRA) when there were missing data
RITA (n  332)‡ RA (n  324)‡
n % n %
Death (in-hospital or during follow-up) 5 1.5 1 0.3
Myocardial infarct (in-hospital or during follow-up) 10 3.0 5 1.5
Repeat coronary artery bypass graft 1 0.3 0 0.0
Repeat percutaneous transluminal coronary angioplasty 2 0.6 3 0.9
Recurrent anginas 31 9.3 10 3.1
Total no. of patients with cardiac-related events 43 11.1 15 4.1
*Median duration of follow-up was 655 days (1.79 years) and 564 days (1.54 years) for the RITA and RA groups, respectively.
†Patients could experience more than one cardiac-related event, and therefore frequencies of separate event categories do not sum to the total number
of events.
‡Five patients (4 who had a RITA graft and 1 who had an RA graft) were lost to follow-up.
§The outcome of recurrent angina is defined in the text.
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important. Nevertheless, the survival analysis for the com-
bined outcome of all causes of death or cardiac-related
events clearly shows a difference between the 2 groups up
to 4 and 5 years, and there does not appear to be any
tendency for convergence between the 2 survival curves
with increasing duration of follow-up. It therefore seems
unlikely that these differences will disappear with longer
follow-up.
Conclusions
In summary, this study shows that the outcomes of CABG
with 2 arterial grafts are better if the RA is used for the
second graft rather than the RITA, despite an increased
prevalence of risk factors in the RA group and assuming
that the LITA is used for the first arterial graft. On the basis
of existing reports about RA grafts in the literature and our
own experience described in this article, we believe that the
RA should be used more often for myocardial revascular-
ization. However, the question of which conduit to use as
the second artery of choice can only be answered unequiv-
ocally by obtaining long-term results from randomized con-
trolled trials.
We thank Mr A. J. Bryan, Mr J. Hutter, Mr F. Ciulli, and Mr
M. Underwood for their surgical contribution.
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